Company Overview

Neuralieve is a medical technology company that is utilizing transcranial magnetic stimulation (TMS) technology to deliver therapy. Scientific understanding of the importance of electrical signaling in brain function is growing, and there is great potential for neurostimulation as a therapeutic tool. TMS is a proven, safe method of studying the brain that has been used for years. It works by creating a focused magnetic pulse that passes non-invasively through the skull, inducing an electric current. This sends a signal by stimulating the neurons.

Neuralieve has developed the first portable "home-use" TMS Treatment System. The first application will be migraine therapy. Neuralieve's TMS Treatment System is used to stimulate the brain's occipital cortex, inducing a signal that is intended to disrupt cortical spreading depression (CSD), the abnormal brain waves which precede migraine. Scientific experiments have suggested that disrupting the wave of CSD may reduce or eliminate the pain associated with a migraine episode.